Confirm fentanyl is listed
A generic “drug test” label does not establish that a product includes fentanyl. Check the individual product’s analyte list and technical configuration. When the listing is unclear or its fields disagree, get written supplier confirmation before selecting it for a program requirement.
Some products use a standalone format while others combine targets on a cup. Compare format, stored targets, and cutoff text instead of relying on panel count, a SKU abbreviation, or a general category label.
Treat the result as presumptive screening
Rapid screens have product-specific procedures and limitations. Follow the exact instructions included with the selected test, including the stated specimen handling and read window. A screening result does not by itself establish a complete clinical finding or identify every substance that may be present.
The appropriate next step depends on the purpose of testing, the product labeling, and the rules or policies that govern the program. Document how staff should handle an unexpected or disputed result before introducing a product into routine use.
Keep product and program records aligned
When evaluating a supply option, retain the SKU, product instructions, stated configuration, and supplier clarification together. Recheck those documents if a product or variant changes; do not carry specifications from a former item to its replacement.
Federal workplace guidance is one authoritative source for programs within its scope, but it does not replace organization-specific clinical, employment, or other regulatory review.